On behalf of the Beljanski Foundation, it is my great pleasure to announce that another research article from The University of Kansas Medical Center, confirming Professor Mirko Beljanski’s work has just recently come out!
The article entitled “Inhibition of pancreatic cancer and potentiation of Gemcitabine effects by the extract of Pao Pereira”, not only verifies Professor Beljanski’s body of work, but also expands on it thus representing a great step in the Beljanski Foundation’s mission. Due to be published in July in the Oncology Reports Journal, this article helps to confirm the therapeutic use of the Pao Pereira extract.
As one of the most lethal types of cancer in the world, the lack of effective therapy is a major problem with the treatment of pancreatic cancer. As the 4th leading cause of cancer related fatalities, Pancreatic Cancer patients have an overall 5-year survival rate of only 3-5%, due to limited early detection tools, the aggressive nature of the disease, and limited treatment options.
New pre-clinical studies conducted with mice, both in vitro an in vivo, confirm that adding Pao Pereira to the treatment regiment reduced the concentration of Gemcitabine to produce an equitoxic effect on pancreatic cancer cells. The Pao’s anti-cancer effect was seen in vivo and in vitro working alone and in conjunction with other chemotherapy treatments. Over the course of the study, the Pao was seen to suppress tumor growth significantly, by up to 72%.
This confirms another study, published just a few years ago, out of Columbia University demonstrating that the two plant extracts, Pao Pereira and Rauwolfia Vomitoria, contain Beta-Carbolines with effective anti-cancer properties which inhibit cancer cell growth, even in those cells resistant to drugs used in chemotherapy. This study, specific to anti-prostate cancer activity, also substantiated that all healthy cells were not negatively affected, thus demonstrating the safety of the plant extracts prepared by the Beljanski method.
With such promising initial results, the research will continue on Pao Paereira to assess its effectiveness on other types of cancerous cells!